Shell Asset Management CO Gilead Sciences, Inc. Transaction History
Shell Asset Management CO
- $2.11 Billion
- Q1 2025
A detailed history of Shell Asset Management CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 64,563 shares of GILD stock, worth $7.13 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
64,563
Previous 66,635
3.11%
Holding current value
$7.13 Million
Previous $6.16 Million
17.53%
% of portfolio
0.34%
Previous 0.27%
Shares
32 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.57 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.03 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...